William J. Aronson
#167,180
Most Influential Person Now
William J. Aronson's AcademicInfluence.com Rankings
William J. Aronsonengineering Degrees
Engineering
#7441
World Rank
#8815
Historical Rank
Biomedical Engineering
#751
World Rank
#763
Historical Rank

William J. Aronsonphilosophy Degrees
Philosophy
#9893
World Rank
#13515
Historical Rank
Logic
#6843
World Rank
#8397
Historical Rank

Download Badge
Engineering Philosophy
William J. Aronson's Degrees
- Doctorate Medicine Harvard University
Why Is William J. Aronson Influential?
(Suggest an Edit or Addition)William J. Aronson's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Radical prostatectomy versus observation for localized prostate cancer. (2012) (1359)
- Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic Neurotransmission (1992) (638)
- Intensive lifestyle changes may affect the progression of prostate cancer. (2005) (438)
- Follow‐up of Prostatectomy versus Observation for Early Prostate Cancer (2017) (430)
- Phase II Study of Pomegranate Juice for Men with Rising Prostate-Specific Antigen following Surgery or Radiation for Prostate Cancer (2006) (418)
- Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. (1992) (409)
- Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group. (2004) (398)
- Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. (2007) (332)
- The correlation between metabolic syndrome and prostatic diseases. (2012) (317)
- Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland. (2007) (275)
- Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Prostate-specific antigen. (2003) (264)
- Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study. (2005) (254)
- Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality. (2019) (236)
- Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer (2018) (221)
- Nitric oxide is a potent relaxant of human and rabbit corpus cavernosum. (1992) (185)
- Impact of diet on prostate cancer: a review (2005) (172)
- Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications. (2006) (166)
- Effect of Altering Dietary ω-6/ω-3 Fatty Acid Ratios on Prostate Cancer Membrane Composition, Cyclooxygenase-2, and Prostaglandin E2 (2006) (153)
- Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy (2006) (153)
- Carbohydrate restriction, prostate cancer growth, and the insulin‐like growth factor axis (2008) (149)
- Modulation of omega-3/omega-6 polyunsaturated ratios with dietary fish oils in men with prostate cancer. (2001) (148)
- Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score. (2002) (144)
- Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption. (2006) (143)
- Predictors of metastatic disease in men with biochemical failure following radical prostatectomy. (2004) (135)
- Time trends in biochemical recurrence after radical prostatectomy: results of the SEARCH database. (2003) (134)
- Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-κB-dependent mechanism (2008) (129)
- Ellagitannin-rich pomegranate extract inhibits angiogenesis in prostate cancer in vitro and in vivo. (2008) (127)
- Nutrition, dietary interventions and prostate cancer: the latest evidence (2015) (126)
- Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. (2006) (124)
- Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro (United States) (2002) (123)
- The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer. (2009) (121)
- Nitric oxide and cGMP: mediators of pelvic nerve-stimulated erection in dogs. (1993) (121)
- Statin medication use and the risk of biochemical recurrence after radical prostatectomy (2010) (120)
- A low‐fat diet and/or strenuous exercise alters the IGF axis in vivo and reduces prostate tumor cell growth in vitro (2003) (119)
- Insulin-like growth factor I (IGF-I) and IGF binding protein-1 modulate prostate cancer cell growth and apoptosis: possible mediators for the effects of diet and exercise on cancer cell survival. (2003) (116)
- Multi-institutional validation of the CAPRA-S score to predict disease recurrence and mortality after radical prostatectomy. (2014) (113)
- Phenolic Acid Concentrations in Plasma and Urine from Men Consuming Green or Black Tea and their Chemopreventive Properties for Colon Cancer (2012) (109)
- Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10 (2006) (107)
- Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. (2002) (106)
- Serum Lipid Profile and Risk of Prostate Cancer Recurrence: Results from the SEARCH Database (2014) (106)
- Prostate cancer: another aspect of the insulin‐resistance syndrome? (2002) (103)
- Obesity is a significant risk factor for prostate cancer at the time of biopsy. (2008) (102)
- Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database. (2003) (97)
- Effect of altering dietary omega-6/omega-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2. (2006) (97)
- Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins. (2004) (96)
- Exercise alters the IGF axis in vivo and increases p53 protein in prostate tumor cells in vitro. (2004) (91)
- Effect of isocaloric low-fat diet on human LAPC-4 prostate cancer xenografts in severe combined immunodeficient mice and the insulin-like growth factor axis. (2003) (91)
- Green Tea Polyphenols and Metabolites in Prostatectomy Tissue: Implications for Cancer Prevention (2010) (91)
- Decreased growth of human prostate LNCaP tumors in SCID mice fed a low-fat, soy protein diet with isoflavones. (1999) (90)
- Effect of low-fat diet on development of prostate cancer and Akt phosphorylation in the Hi-Myc transgenic mouse model. (2008) (85)
- Evidence of an inhibitory effect of diet and exercise on prostate cancer cell growth. (2001) (85)
- Effects of diet and exercise on insulin, sex hormone-binding globulin, and prostate-specific antigen. (1998) (83)
- Growth inhibitory effect of low fat diet on prostate cancer cells: results of a prospective, randomized dietary intervention trial in men with prostate cancer. (2010) (82)
- Delayed radical prostatectomy for intermediate‐risk prostate cancer is associated with biochemical recurrence: Possible implications for active surveillance from the SEARCH database (2013) (82)
- Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis. (2017) (81)
- Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT). (1997) (80)
- Obesity is associated with castration‐resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database (2012) (78)
- Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration‐resistant prostate cancer, and mortality after radical prostatectomy (2014) (76)
- Outcomes after radical prostatectomy among men who are candidates for active surveillance: results from the SEARCH database. (2008) (75)
- Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center. (2000) (74)
- Predicting Time From Metastasis to Overall Survival in Castration‐Resistant Prostate Cancer: Results From SEARCH (2017) (72)
- Association between tumor-associated macrophage infiltration, high grade prostate cancer, and biochemical recurrence after radical prostatectomy. (2013) (72)
- Changing nature of high risk patients undergoing radical prostatectomy. (2007) (71)
- Phase II Prospective Randomized Trial of a Low-Fat Diet with Fish Oil Supplementation in Men Undergoing Radical Prostatectomy (2011) (67)
- Randomized clinical trial of brewed green and black tea in men with prostate cancer prior to prostatectomy (2015) (67)
- Obesity as a predictor of adverse outcome across black and white race (2009) (67)
- Do younger men have better biochemical outcomes after radical prostatectomy? (2004) (66)
- Examining the relationship between obesity and prostate cancer. (2004) (66)
- Race, biochemical disease recurrence, and prostate–specific antigen doubling time after radical prostatectomy (2007) (64)
- Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH database. (2007) (62)
- Small transrectal ultrasound volume predicts clinically significant Gleason score upgrading after radical prostatectomy: results from the SEARCH database. (2008) (62)
- Should a positive surgical margin following radical prostatectomy be pathological stage T2 or T3? Results from the SEARCH database. (2003) (62)
- A mechanism to explain how regular exercise might reduce the risk for clinical prostate cancer (2007) (61)
- Prostate cancer severity among low income, uninsured men. (2008) (61)
- Chemoprevention of prostate cancer with lycopene in the TRAMP model (2010) (60)
- Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: results from the SEARCH database. (2003) (59)
- Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database (2013) (58)
- Preoperative p27 status is an independent predictor of prostate specific antigen failure following radical prostatectomy. (2003) (57)
- Obesity and oncological outcome after radical prostatectomy: impact of prostate‐specific antigen‐based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center Databases (2008) (56)
- Delay of radical prostatectomy and risk of biochemical progression in men with low risk prostate cancer. (2006) (56)
- Clinical characteristics in black and white men with prostate cancer in an equal access medical center. (2000) (55)
- Preoperative model for predicting prostate specific antigen recurrence after radical prostatectomy using percent of biopsy tissue with cancer, biopsy Gleason grade and serum prostate specific antigen. (2004) (55)
- Late parasitemia in asymptomatic acquired toxoplasmosis. (1969) (55)
- The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy (2003) (55)
- Risk stratification of men with Gleason score 7 to 10 tumors by primary and secondary Gleason score: results from the SEARCH database. (2007) (54)
- Predictors of Time to Metastasis in Castration-resistant Prostate Cancer. (2016) (52)
- Obesity and positive surgical margins by anatomic location after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database (2008) (51)
- Effect of Dietary Omega‐3 Fatty Acids on Tumor‐Associated Macrophages and Prostate Cancer Progression (2016) (51)
- Comparison of preoperative prostate specific antigen density and prostate specific antigen for predicting recurrence after radical prostatectomy: results from the search data base. (2003) (51)
- Role of Testosterone, Estradiol, and Insulin in Diet- and Exercise-Induced Reductions in Serum-Stimulated Prostate Cancer Cell Growth In Vitro (2002) (50)
- Pathological and Biochemical Outcomes among African-American and Caucasian Men with Low Risk Prostate Cancer in the SEARCH Database: Implications for Active Surveillance Candidacy. (2016) (48)
- Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database (2014) (48)
- A randomized, double-blind, placebo-controlled study of the effects of pomegranate extract on rising PSA levels in men following primary therapy for prostate cancer (2015) (48)
- MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer (2019) (47)
- Nutrition and prostate cancer. (1999) (47)
- PSA in the new millennium: a powerful predictor of prostate cancer prognosis and radical prostatectomy outcomes--results from the SEARCH database. (2008) (46)
- Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy. (2004) (45)
- Preoperative PSA velocity and doubling time do not predict adverse pathologic features or biochemical recurrence after radical prostatectomy. (2001) (45)
- Glycemic control and prostate cancer progression: Results from the SEARCH database (2010) (44)
- Effect of Isocaloric Low-Fat Diet on Prostate Cancer Xenograft Progression to Androgen Independence (2004) (44)
- Diabetes and Outcomes After Radical Prostatectomy: Are Results Affected by Obesity and Race? Results from the Shared Equal-Access Regional Cancer Hospital Database (2010) (42)
- Validation of a nomogram to predict disease progression following salvage radiotherapy after radical prostatectomy: results from the SEARCH database (2009) (42)
- Thresholds for PSA doubling time in men with non‐metastatic castration‐resistant prostate cancer (2017) (42)
- Risk factors for male osteoporosis. (2003) (42)
- Predictors of prostate‐specific antigen progression among men with seminal vesicle invasion at the time of radical prostatectomy (2004) (41)
- Natural history of persistently elevated prostate specific antigen after radical prostatectomy: results from the SEARCH database. (2009) (41)
- Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score. (2002) (41)
- Obesity and prostate cancer-specific mortality after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database (2016) (40)
- Obesity and prostate cancer. (2005) (40)
- A lifestyle intervention of weight loss via a low-carbohydrate diet plus walking to reduce metabolic disturbances caused by androgen deprivation therapy among prostate cancer patients: carbohydrate and prostate study 1 (CAPS1) randomized controlled trial (2019) (39)
- Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate. (2020) (38)
- Effect of race and socioeconomic status on surgical margins and biochemical outcomes in an equal‐access health care setting (2012) (38)
- Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH database (2017) (36)
- A natural history of weight change in men with prostate cancer on androgen‐deprivation therapy (ADT): results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database (2011) (35)
- Obesity, prostate-specific antigen nadir, and biochemical recurrence after radical prostatectomy: biology or technique? Results from the SEARCH database. (2012) (35)
- Do skeletal-related events predict overall survival in men with metastatic castration-resistant prostate cancer? (2016) (34)
- An update of research evidence on nutrition and prostate cancer. (2017) (34)
- Dietary intervention strategies to modulate prostate cancer risk and prognosis (2009) (34)
- Biochemical outcome after radical prostatectomy among men with normal preoperative serum prostate‐specific antigen levels (2004) (34)
- Risk stratification for biochemical recurrence in men with positive surgical margins or extracapsular disease after radical prostatectomy: results from the SEARCH database. (2008) (33)
- Fish Oil Slows Prostate Cancer Xenograft Growth Relative to Other Dietary Fats and is Associated with Decreased Mitochondrial and Insulin Pathway Gene Expression (2013) (33)
- Analyzing Serum-Stimulated Prostate Cancer Cell Lines After Low-Fat, High-Fiber Diet and Exercise Intervention (2011) (32)
- Body mass index, prostate weight and transrectal ultrasound prostate volume accuracy. (2007) (32)
- Is biopsy Gleason score independently associated with biochemical progression following radical prostatectomy after adjusting for pathological Gleason score? (2006) (31)
- Association of cigarette smoking with interval to biochemical recurrence after radical prostatectomy: results from the SEARCH database. (2010) (31)
- Optimal timing, cutoff, and method of calculation of preoperative prostate-specific antigen velocity to predict relapse after prostatectomy: a report from SEARCH. (2007) (30)
- Effect of diet and exercise intervention on the growth of prostate epithelial cells (2008) (30)
- Impact of nerve sparing on surgical margins and biochemical recurrence: results from the SEARCH database (2009) (29)
- Feasibility of a low-fat/high-fiber diet intervention with soy supplementation in prostate cancer patients after prostatectomy (2008) (29)
- Neutrophil, lymphocyte and platelet counts, and risk of prostate cancer outcomes in white and black men: results from the SEARCH database (2018) (29)
- The association between prostate size and Gleason score upgrading depends on the number of biopsy cores obtained: results from the Shared Equal Access Regional Cancer Hospital Database (2008) (28)
- Predicting bone scan positivity in non-metastatic castration-resistant prostate cancer (2015) (27)
- Race and Time from Diagnosis to Radical Prostatectomy: Does Equal Access Mean Equal Timely Access to the Operating Room?—Results from the SEARCH Database (2009) (27)
- The impact of pathologic staging on the long‐term oncologic outcomes of patients with clinically high‐risk prostate cancer (2014) (26)
- Effect of a Low-Fat Fish Oil Diet on Proinflammatory Eicosanoids and Cell-Cycle Progression Score in Men Undergoing Radical Prostatectomy (2013) (26)
- Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database. (2003) (26)
- Polycythemia Rubra Vera and Pregnancy (1983) (26)
- Definition and preoperative predictors of persistently elevated prostate‐specific antigen after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database (2010) (25)
- What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group. (2008) (25)
- Effects of Calorie Restriction and IGF-1 Receptor Blockade on the Progression of 22Rv1 Prostate Cancer Xenografts (2013) (24)
- Do nomograms predict aggressive recurrence after radical prostatectomy more accurately than biochemical recurrence alone? (2009) (24)
- Number of Unfavorable Intermediate‐Risk Factors Predicts Pathologic Upstaging and Prostate Cancer‐Specific Mortality Following Radical Prostatectomy: Results From the SEARCH Database (2017) (24)
- Clinical utility of percent prostate needle biopsy tissue with cancer cutpoints to risk stratify patients before radical prostatectomy. (2002) (24)
- Detectable prostate-specific antigen Nadir during androgen-deprivation therapy predicts adverse prostate cancer-specific outcomes: results from the SEARCH database. (2014) (24)
- Impact of age, comorbidity, and PSA doubling time on long-term competing risks for mortality among men with non-metastatic castration-resistant prostate cancer (2018) (24)
- Exposure to Agent Orange is a significant predictor of prostate‐specific antigen (PSA)‐based recurrence and a rapid PSA doubling time after radical prostatectomy (2009) (24)
- Obesity, race, and long‐term prostate cancer outcomes (2020) (23)
- Predictors of secondary treatment following biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database (2010) (23)
- Factors predicting skeletal‐related events in patients with bone metastatic castration‐resistant prostate cancer (2017) (22)
- Positive surgical margins in radical prostatectomy patients do not predict long‐term oncological outcomes: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) cohort (2016) (22)
- Long-term oncological outcomes of apical positive surgical margins at radical prostatectomy in the Shared Equal Access Regional Cancer Hospital cohort (2016) (21)
- Multivariate analysis of race and adverse pathologic findings after radical prostatectomy. (2000) (21)
- Do racial differences in prostate size explain higher serum prostate-specific antigen concentrations among black men? (2007) (21)
- Preoperative weight change and risk of adverse outcome following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database (2011) (20)
- Freedom from a detectable ultrasensitive prostate-specific antigen at two years after radical prostatectomy predicts a favorable clinical outcome: analysis of the SEARCH database. (2010) (20)
- Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease (2019) (19)
- Is a positive bladder neck margin truly a T4 lesion in the prostate specific antigen era? Results from the SEARCH Database. (2008) (19)
- Effect of a Low-Fat Diet Combined with IGF-1 Receptor Blockade on 22Rv1 Prostate Cancer Xenografts (2012) (19)
- Body mass index and prostate specific antigen as predictors of adverse pathology and biochemical recurrence after prostatectomy. (2009) (19)
- Effect of Dietary Omega-3 Fatty Acids on Castrate Resistant Prostate Cancer and Tumor Associated Macrophages (2019) (19)
- Validation of the 2015 prostate cancer grade groups for predicting long‐term oncologic outcomes in a shared equal‐access health system (2017) (18)
- Is clinical stage T2c prostate cancer an intermediate‐ or high‐risk disease? (2015) (18)
- Phase II Prospective Randomized Trial of Weight Loss Prior to Radical Prostatectomy (PCAN-17-0128) (2017) (18)
- Do nomograms designed to predict biochemical recurrence (BCR) do a better job of predicting more clinically relevant prostate cancer outcomes than BCR? A report from the SEARCH database group. (2013) (18)
- Does PSADT after radical prostatectomy correlate with overall survival?--a report from the SEARCH database group. (2011) (18)
- Predicting biochemical recurrence after radical prostatectomy for patients with organ-confined disease using p27 expression. (2003) (18)
- Poorly controlled diabetes increases the risk of metastases and castration‐resistant prostate cancer in men undergoing radical prostatectomy: Results from the SEARCH database (2019) (18)
- Preclinical models relevant to diet, exercise, and cancer risk. (2005) (17)
- Timing of Prostate-specific Antigen Nadir After Radical Prostatectomy and Risk of Biochemical Recurrence. (2017) (17)
- Limitations of prostate specific antigen doubling time following biochemical recurrence after radical prostatectomy: results from the SEARCH database. (2008) (17)
- Role of Host GPR120 in Mediating Dietary Omega-3 Fatty Acid Inhibition of Prostate Cancer (2018) (17)
- Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis. (2020) (17)
- Do all men with pathological Gleason score 8–10 prostate cancer have poor outcomes? Results from the SEARCH database (2016) (16)
- Building a medical neighborhood in the safety net: an innovative technology improves hematuria workups. (2013) (16)
- Socioeconomic status, race, and long-term outcomes after radical prostatectomy in an equal access health system: Results from the SEARCH database. (2019) (16)
- Preoperative predictors of blood loss at the time of radical prostatectomy: results from the SEARCH database (2009) (16)
- Benign Prostatic Hyperplasia: Does Lifestyle Play a Role? (2009) (16)
- The effect of race/ethnicity on the accuracy of the 2001 Partin Tables for predicting pathologic stage of localized prostate cancer. (2008) (15)
- PI-LBA06 VA CSP#553 CHEMOTHERAPY AFTER PROSTATECTOMY (CAP) FOR HIGH RISK PROSTATE CARCINOMA: A PHASE III RANDOMIZED STUDY (2016) (14)
- Obesity, risk of biochemical recurrence, and prostate‐specific antigen doubling time after radical prostatectomy: results from the SEARCH database (2018) (14)
- Prostate‐specific antigen level, stage or Gleason score: Which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database (2015) (14)
- Predictors of operative time during radical retropubic prostatectomy and robot‐assisted laparoscopic prostatectomy (2017) (14)
- Global Igfbp1 deletion does not affect prostate cancer development in a c-Myc transgenic mouse model. (2011) (14)
- Does early prostate‐specific antigen doubling time (ePSADT) after radical prostatectomy, calculated using PSA values from the first detectable until the first recurrence value, correlate with standard PSADT? A report from the Shared Equal Access Regional Cancer Hospital Database Group (2009) (14)
- Racial Differences in the Association Between Preoperative Serum Cholesterol and Prostate Cancer Recurrence: Results from the SEARCH Database (2016) (14)
- Are repeat prostate biopsies safe? A cohort analysis from the SEARCH database. (2012) (14)
- Predicting bone scan positivity after biochemical recurrence following radical prostatectomy in both hormone-naive men and patients receiving androgen-deprivation therapy: results from the SEARCH database (2014) (14)
- Segmental testicular infarction in the neonate: a case report. (1995) (14)
- Exclusion of the uniform tetraploid cells significantly improves specificity of the urine fish assay (2013) (13)
- Diabetes predicts metastasis after radical prostatectomy in obese men: results from the SEARCH database (2013) (13)
- The Influence of Hepatic Function on Prostate Cancer Outcomes Following Radical Prostatectomy (2010) (13)
- Impact of prior local therapy on overall survival in men with metastatic castration‐resistant prostate cancer: Results from Shared Equal Access Regional Cancer Hospital (2018) (13)
- Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study. (2017) (13)
- Biopsy Detected Gleason Pattern 5 is Associated with Recurrence, Metastasis and Mortality in a Cohort of Men with High Risk Prostate Cancer (2017) (13)
- The effect of race on the discriminatory accuracy of models to predict biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases (2010) (13)
- Variations in payment patterns for surgical care in the centers for Medicare and Medicaid Services (2017) (12)
- Keratin 13 Is Enriched in Prostate Tubule-Initiating Cells and May Identify Primary Prostate Tumors that Metastasize to the Bone (2016) (12)
- Validity of the National Death Index to Ascertain the Date and Cause of Death in Men Having Undergone Prostatectomy for Prostate Cancer (2019) (12)
- Postoperative prostate‐specific antigen nadir improves accuracy for predicting biochemical recurrence after radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) and Duke Prostate Center databases (2010) (12)
- Predictors of skeletal‐related events and mortality in men with metastatic, castration‐resistant prostate cancer: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database (2019) (12)
- Estimated blood loss as a predictor of PSA recurrence after radical prostatectomy: results from the SEARCH database (2010) (11)
- Prospective randomized trial evaluating blood and prostate tissue concentrations of green tea polyphenols and quercetin in men with prostate cancer. (2020) (11)
- Obese patients with castration‐resistant prostate cancer may be at a lower risk of all‐cause mortality: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database (2018) (11)
- First postoperative PSA is associated with outcomes in patients with node positive prostate cancer: Results from the SEARCH database. (2018) (11)
- Radical prostatectomy and the effect of close surgical margins: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database (2018) (10)
- PD43-02 ARE WE OPERATING ON WHO WE SHOULD? THE CHANGING CHARACTERISTICS OF RADICAL PROSTATECTOMY PATIENTS: RESULTS FROM THE SHARED EQUAL ACCESS REGIONAL CANCER HOSPITAL (SEARCH) DATABASE (2016) (10)
- In Men with Castration-Resistant Prostate Cancer, Visceral Metastases Predict Shorter Overall Survival: What Predicts Visceral Metastases? Results from the SEARCH Database. (2016) (10)
- Is Ki67 prognostic for aggressive prostate cancer? A multicenter real-world study. (2018) (10)
- Commentary on "Biallelic inactivation of BRCA2 in platinum-sensitive metastatic castration-resistant prostate cancer". Cheng HH, Pritchard CC, Boyd T, Nelson PS, Montgomery B. Eur Urol. Jun 2016;69(6):992-5. (2017) (10)
- Smoking is a predictor of adverse pathological features at radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital database (2015) (10)
- Practice patterns and predictors of followup imaging after a negative bone scan in men with castration resistant prostate cancer: results from the SEARCH database. (2015) (10)
- Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database. (2007) (10)
- Re‐calibration and external validation of an existing nomogram to predict aggressive recurrences after radical prostatectomy (2009) (9)
- Veterans Affairs Cooperative Studies Program Study #553: Chemotherapy After Prostatectomy for High-risk Prostate Carcinoma: A Phase III Randomized Study. (2020) (9)
- Race does not predict the development of metastases in men with nonmetastatic castration‐resistant prostate cancer (2016) (9)
- Cautery-Wire/Balloon Catheter for Fluoroscopically Guided Incision of Ureteral Strictures: A Phase I Study in Pigs (1991) (9)
- Adverse pathology and undetectable ultrasensitive prostate‐specific antigen after radical prostatectomy: is adjuvant radiation warranted? (2016) (9)
- Validation of a bone scan positivity risk table in non‐metastatic castration‐resistant prostate cancer (2016) (9)
- Racial Discrepancies in Overall Survival among Men Treated with Radium-223. (2019) (9)
- Competing Risks of Mortality Among Men with Biochemical Recurrence after Radical Prostatectomy. (2020) (8)
- Does Early Prostate Specific Antigen Doubling Time after Radical Prostatectomy, Calculated Prior to Prostate Specific Antigen Recurrence, Correlate with Prostate Cancer Outcomes? A Report from the SEARCH Database Group (2017) (7)
- Modified risk stratification grouping using standard clinical and biopsy information for patients undergoing radical prostatectomy: Results from SEARCH (2017) (7)
- 1418: Can Hemodilution Explain the Lower PSA Concentrations Among Obese Men? (2007) (7)
- Is there a difference in outcome after radical prostatectomy between patients with biopsy Gleason sums 4, 5, and 6? results from the SEARCH database (2003) (7)
- EDITORIAL: CAN WE LOWER THE MORTALITY RATE OF BLACK MEN WITH PROSTATE CANCER? (2000) (7)
- Statins are Associated With Increased Biochemical Recurrence After Radical Prostatectomy in Diabetic Men but no Association was Seen in Men also Taking Metformin: Results From the SEARCH Database (2019) (6)
- Characterization of a “low‐risk” cohort of grade group 2 prostate cancer patients: Results from the Shared Equal Access Regional Cancer Hospital database (2017) (6)
- Invited commentary: Lower urinary tract symptoms and inflammation--weighing the evidence. (2009) (6)
- Is computed tomography a necessary part of a metastatic evaluation for castration‐resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital Database (2016) (6)
- Time Trends in Use of Radical Prostatectomy by Tumor Risk and Life Expectancy in a National Veterans Affairs Cohort (2021) (6)
- The L-arginine-nitric oxide-cyclic GMP pathway mediates inhibitory nonadrenergic-noncholinergic neurotransmission in the corpus cavernosum of human and rabbit (1993) (6)
- Diabetes and Prostate Cancer Outcomes in Obese and Nonobese Men After Radical Prostatectomy (2021) (5)
- Fish oil slows prostate cancer xenograft growth relative to other dietary fats and is associated with decreased mitochondrial and insulin pathway gene expression (2013) (5)
- AJCC Cancer Staging Atlas (2007) (5)
- Nutritional approaches to the prevention of prostate cancer progression. (1996) (5)
- Red Blood Cell Distribution Width Is Associated with All-cause Mortality but Not Adverse Cancer-specific Outcomes in Men with Clinically Localized Prostate Cancer Treated with Radical Prostatectomy: Findings Based on a Multicenter Shared Equal Access Regional Cancer Hospital Registry (2022) (5)
- Agent Orange and long-term outcomes after radical prostatectomy. (2015) (5)
- Association between Delay to Radical Prostatectomy and Clinically Meaningful Outcomes among Patients with Intermediate and High-Risk Localized Prostate Cancer (2021) (5)
- 437: Obesity is an Independent Predictor of Biochemical Failure Following Radical Prostatectomy (2004) (4)
- 1281 Associations Between C-Reactive Protein and Benign Prostatic Hyperplasia/Lower Urinary Tract Symptom Outcomes in a Population-based Cohort. Jennifer L. St. Sauver, (2009) (4)
- LONG TERM FOLLOW UP OF PHASE 2 STUDY OF POMEGRANATE JUICE FOR MEN WITH PROSTATE CANCER SHOWS DURABLE PROLONGATION OF PSA DOUBLING TIME (2009) (4)
- Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: Results from the SEARCH database (2014) (4)
- High serum folate is associated with reduced biochemical recurrence after radical prostatectomy: results from the SEARCH Database. (2013) (4)
- Serum Lipids Prior to Starting Androgen Deprivation Therapy and Risk of Castration-Resistant Prostate Cancer and Metastasis: Results from the SEARCH Database. (2020) (4)
- Re: Weight Loss with a Low-Carbohydrate, Mediterranean, or Low-Fat Diet (2009) (4)
- Erratum: Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy (Cancer (2014), 120 (197-204)) (2015) (4)
- Safety of concomitant therapy with radium‐223 and abiraterone or enzalutamide in a real‐world population (2021) (4)
- 1162: Can Unilateral Prostate Cancer Be Reliably Predicted Based Upon Biopsy Features? (2006) (4)
- Impact of Diet on Prostate Cancer (2005) (4)
- First-year weight loss with androgen-deprivation therapy increases risks of prostate cancer progression and prostate cancer-specific mortality: results from SEARCH (2019) (3)
- Practice patterns and outcomes of equivocal bone scans for patients with castration-resistant prostate cancer: Results from SEARCH (2019) (3)
- The Impact of 18F-DCFPyL PET-CT Imaging on Initial Staging, Radiation, and Systemic Therapy Treatment Recommendations for Veterans With Aggressive Prostate Cancer (2020) (3)
- Does race predict the development of metastases in men who receive androgen‐deprivation therapy for a biochemical recurrence after radical prostatectomy? (2018) (3)
- Obese men undergoing radical prostatectomy: Is robotic or retropubic better to limit positive surgical margins? Results from SEARCH (2020) (3)
- MP04-06 A PROSPECTIVE RANDOMIZED TRIAL OF DIETARY CARBOHYDRATE RESTRICTION FOR MEN INITIATING ANDROGEN DEPRIVATION THERAPY: CARBOHYDRATE AND PROSTATE STUDY I (CAPS1) (2016) (3)
- MP87-09 WHEN IS AN EQUIVOCAL BONE SCAN NOT REALLY EQUIVOCAL? RESULTS FROM SEARCH (2015) (3)
- Influence of African American race on the association between preoperative biopsy grade group and adverse histopathologic features of radical prostatectomy (2019) (3)
- Effects of dietary omega-3 fatty acids on orthotopic prostate cancer progression, tumor associated macrophages, angiogenesis and T-cell activation—dependence on GPR120 (2022) (3)
- 241 DO NOMOGRAMS DESIGNED TO PREDICT BIOCHEMICAL RECURRENCE (BCR) DO A BETTER JOB OF PREDICTING MORE DISTANT PROSTATE CANCER OUTCOMES THAN BCR?–A REPORT FROM THE SEARCH DATABASE GROUP (2010) (3)
- Radiotherapy versus radical prostatectomy for Gleason score 9-10 prostate adenocarcinoma: A multi-institutional comparative analysis of 1001 patients treated in the modern era. (2017) (3)
- 860 DOES BEING ON ADT ALTER THE ABILITY OF PSA AND PSADT TO PREDICT A POSITIVE BONE SCAN? RESULTS FROM THE SEARCH DATABASE (2010) (2)
- RISK STRATIFICATION AMONG MEN WITH POSITIVE SURGICAL MARGINS OR EXTRACAPSULAR DISEASE AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SHARED EQUAL ACCESS REGIONAL CANCER HOSPITAL (SEARCH) DATABASE (2008) (2)
- Prostate weight and prostate cancer outcomes after radical prostatectomy: Results from the SEARCH cohort study (2021) (2)
- Carcinoma of the penis and scrotum (1994) (2)
- OBESITY AS A PREDICTOR OF ADVERSE OUTCOME ACROSS BLACK AND WHITE RACE: RESULTS FROM THE SEARCH AND DUKE PROSTATE CENTER DATABASES (2008) (2)
- 1508: Obesity, Serum PSA, and Prostate Size: Implications for Prostate Cancer Detection (2006) (2)
- Fluoroscopically guided incision of ureteral strictures in pigs with the cautery-wire balloon catheter: a phase 1 study. (1993) (2)
- Is Clinical Stage T 2 C Prostate Cancer Intermediate or High-Risk Disease ? (2015) (2)
- Monocyte counts and prostate cancer outcomes in white and black men: results from the SEARCH database (2021) (1)
- Combination of Quercetin and Green Tea Extract Increased Plasma Epicatechingallate and Decreased Urine Epigallocatechin and Epicatechin Concentrations (2017) (1)
- Can we lower the mortality rate of black men with prostate cancer? (2000) (1)
- Do Hispanic men have worse outcomes after radical prostatectomy? Results from SEARCH: Hispanic men outcomes: Results from SEARCH. (2020) (1)
- Does salvage radiation therapy change the biology of recurrent prostate cancer based on PSA doubling times? Results from the SEARCH database. (2012) (1)
- STATIN MEDICATION USE AND THE RISK OF BIOCHEMICAL RECURRENCE FOLLOWING RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2009) (1)
- 289 ASSOCIATION OF CIGARETTE SMOKING WITH TIME TO BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2010) (1)
- IS PSA A POOR PREDICTOR OF PROSTATE CANCER IN OBESE MEN (2008) (1)
- 131: Agent Orange Exposure and Risk of Advanced Disease and Biochemical Progression after Radical Prostatectomy: Results from the Search Database (2006) (1)
- 1030: Do Younger Men have Better Biochemical Outcomes Following Radical Prostatectomy? (2004) (1)
- BODY MASS INDEX AND PROSTATE-SPECIFIC ANTIGEN AS A PREDICTOR OF ADVERSE PATHOLOGY AND BIOCHEMICAL RECURRENCE FOLLOWING RADICAL PROSTATECTOMY (2009) (1)
- RECALIBRATION AND EXTERNAL VALIDATION OF AN EXISTING NOMOGRAM TO PREDICT AGGRESSIVE RECURRENCES AFTER RADICAL PROSTATECTOMY (RP) (2009) (1)
- Effects of brewed green and black tea on inflammation, apoptosis and oxidation in men with prostate cancer (136.3) (2014) (1)
- 249: Inhibitory Effect of Dietary Fish Oil (Omega-3 Fatty Acids) on Human Prostate Cancer Progression in Severe-Combined Immunodeficient Mice (2005) (1)
- IS PSA A POOR PREDICTOR OF ADVERSE PATHOLOGY AND BIOCHEMICAL FAILURE FOLLOWING RADICAL PROSTATECTOMY IN OBESE MEN (2008) (1)
- Racial Differences in Prognostic Value of Adult Height for Biochemical Progression Following Radical Prostatectomy (2005) (1)
- 97 DOES TYPE OF DIETARY FAT MATTER? PROSTATE CANCER XENOGRAFT PROGRESSION IN A SCID MOUSE MODEL WITH VARYING DIETARY FAT SOURCES (2010) (1)
- Racial disparities in radium-223 treatment in a large real-world population. (2019) (1)
- MP53-01 THE RELATIONSHIP OF OBESITY, PATHOLOGIC GLEASON GRADE AND PROSTATE CANCER TUMOR VOLUME AT THE TIME OF RADICAL PROSTATECTOMY—RESULTS FROM THE SEARCH DATABASE (2015) (1)
- Abstract B67: Inhibition of NFκB and proapoptotic Effect of Green Tea in Prostate Tumor Tissue: A Phase II clinical Trial in Men with Prostate Cancer (2012) (1)
- 2292 PSA NADIR DURING ANDROGEN DEPRIVATION THERAPY PREDICTS ADVERSE PROSTATE CANCER SPECIFIC OUTCOMES: RESULTS FROM THE SEARCH DATABASE (2011) (1)
- Utilization and impact of surgical technique on the performance of pelvic lymph node dissection at radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital database (2016) (1)
- Dietary Omega-6 and Omega-3 Fatty Acids and Prostate Cancer – Response (2012) (1)
- DIABETES AND OUTCOMES AFTER RADICAL PROSTATECTOMY - ARE RESULTS AFFECTED BY OBESITY AND RACE? RESULTS FROM THE SHARED EQUAL ACCESS REGIONAL CANCER HOSPITAL (SEARCH) DATABASE (2009) (1)
- The Impact of Comorbidity and Age on Timing of Androgen Deprivation Therapy in Men with Biochemical Recurrence after Radical Prostatectomy. (2018) (1)
- 2294 OBESE MEN ARE MORE LIKELY TO HAVE HIGHER PSA NADIR VALUES AFTER RADICAL PROSTATECTOMY (RP), THOUGH THIS DOES NOT EXPLAIN THE HIGHER BIOCHEMICAL RECURRENCE (BCR) RATES: RESULTS FROM THE SEARCH DATABASE (2011) (1)
- AJCC Cancer Staging Atlas, F.L. Greene, C.C. Compton, D.P. Winchester, A.G. Fritz, J. Shah. Springer, New York (2006), 352 pages (2007) (1)
- PD14-10 VALIDITY OF THE NATIONAL DEATH INDEX TO ACCURATELY CODE THE DATE OF DEATH AND DEATHS FROM PROSTATE CANCER, IN MEN HAVING UNDERGONE PROSTATECTOMY (2018) (1)
- Can Gleason 7 prostate cancer ever be low-risk? Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. (2015) (1)
- Salvage Radiotherapy for Recurrent Prostate Cancer: Can the Prognostic Grade Group System Inform Treatment Timing? (2019) (1)
- WHAT ARE THE FACTORS ASSOCIATED WITH A SHORT PSA DOUBLING TIME? A REPORT FROM THE SEARCH DATABASE GROUP (2008) (1)
- Do Racial Differences In Prostate Size Explain Higher Serum PSA Concentrations Among Black Men? (2012) (1)
- RADICAL PROSTATECTOMY VERSUS OBSERVATION FOR EARLY PROSTATE CANCER: FOLLOW‐UP RESULTS OF THE PROSTATE CANCER INTERVENTION VERSUS OBSERVATION TRIAL (PIVOT): PNFLBA‐11 (2017) (1)
- MP78-03 PREDICTORS OF TIME TO METASTASIS IN NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (2014) (1)
- PD38-11 ADVERSE PATHOLOGY YET UNDETECTABLE ULTRASENSITIVE PSA: IS ADJUVANT RADIATION REALLY NECESSARY? (2015) (1)
- DOES EARLY PSADT (EPSADT) AFTER RADICAL PROSTATECTOMY, CALCULATED PRIOR TO PSA RECURRENCE, CORRELATE WITH PROSTATE CANCER (PC) OUTCOMES? RESULTS FROM THE SEARCH DATABASE: PD40‐07 (2017) (1)
- Race does not predict skeletal‐related events and all‐cause mortality in men with castration‐resistant prostate cancer (2020) (1)
- Effect of the ERα agonist, GTx-758 (250 mg daily), on total and free testosterone, and PSA, in men with castration resistant prostate cancer (CRPC) maintained on LHRH therapy. (2015) (1)
- MP34-11 OBESITY, RISK OF BIOCHEMICAL RECURRENCE, AND PSADT AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2018) (1)
- 64 THE EFFECT OF RACE AND SOCIOECONOMIC STATUS ON SURGICAL MARGINS AND BIOCHEMICAL OUTCOMES IN AN EQUAL-ACCESS HEALTHCARE SETTING: RESULTS FROM THE SEARCH DATABASE (2012) (1)
- Utilization and impact of surgical technique on the performance of pelvic lymph node dissection at radical prostatectomy: Results from the SEARCH database. (2015) (1)
- Abstract B68: Antioxidant activity of green tea: A phase II clinical trial in men with prostate cancer (2012) (1)
- Chapter 38 – COMPLICATIONS OF URETERAL SURGERY (2010) (1)
- Phase 2 Trial of GTx-758, an Estrogen Receptor Alpha Agonist, in Men With Castration-Resistant Prostate Cancer. (2020) (1)
- Radium-223 treatment patterns in a large real-world population. (2019) (0)
- IN MEN WITH CASTRATION‐RESISTANT PROSTATE CANCER VISCERAL METASTASES PREDICTS SHORTER OVERALL SURVIVAL: WHAT PREDICTS VISCERAL METASTASES? RESULTS FROM THE SEARCH DATABASE: PD24‐09 (2017) (0)
- MP87-08 IS COMPUTERIZED TOMOGRAPHY A NECESSARY PART OF A PROSTATE CANCER METASTATIC WORKUP? RESULTS FROM SEARCH (2015) (0)
- 683P Correlation between castration resistant prostate cancer (CRPC) free survival (CRPC-FS) and metastasis free survival (MFS) in men initiating androgen deprivation therapy (ADT) for biochemical recurrence (BCR) after radical prostatectomy (RP): Results from the SEARCH database (2020) (0)
- Does salvage radiation therapy (SRT) change the biology of recurrent prostate cancer (PCa) based on PSA doubling times (PSADT)? Results from the SEARCH database. (2012) (0)
- 393: African American Race, Risk of Biochemical Recurrence, and Psadt after Radical Prostatectomy (2007) (0)
- PD32-03 A PHASE 2 OPEN-LABEL TRIAL OF GTX-758 IN MEN WITH CASTRATION-RESISTANT PROSTATE CANCER, FINAL ANALYSIS OF THE PRIMARY ENDPOINT (2016) (0)
- A 60-year-old man with gross hematuria and flank pain. (2014) (0)
- Is clinical stage T2c prostate cancer intermediate- or high-risk disease? Results from the SEARCH database. (2014) (0)
- NITRICOXIDE AS A MEDIATOR OF RELAXATION OF THE CORPUS CAVERNOSUM. AUTHOR'SREPLIES (1992) (0)
- CLINICAL CHARACTERISTICS AND SURGICAL OUTCOME IN BLACK AND WHITE MEN WITH PROSTATE CANCER IN AN EQUAL ACCESS MEDICAL CENTER (1999) (0)
- ANALYSIS OF THE PREDICTIVE UTILITY OF PROGNOSTIC GRADE GROUPS (PGG) FOR PREDICTING PERIOPERATIVE ONCOLOGIC OUTCOMES OF RADICAL PROSTATECTOMY IN THE SHARED EQUAL ACCESS REGIONAL CANCER HOSPITAL (SEARCH) DATABASE: PD10‐11 (2017) (0)
- 719 SALVAGE RADIATION THERAPY AFTER RECURRENT PROSTATE CANCER: HOW EARLY DO WE NEED TO BE ? (2013) (0)
- 328: Are the Partin Tables Accurate for African-American men in the United States? (2007) (0)
- Prospective study on the value of PSMA-based 18F-DCFPyL PET/CT scanning in the evaluation of patients with prostate cancer: how does it change the clinical management? (2021) (0)
- 846: Is a Positive Bladder Neck Margin Truly a T4 Lesion in the PSA ERA? Results from the Search Database (2007) (0)
- 644 OBESITY IS ASSOCIATED WITH CASTRATE RESISTANT DISEASE AND METASTASIS IN MEN TREATED WITH ANDROGEN DEPRIVATION THERAPY (ADT) FOR PSA-ONLY RECURRENCE AFTER RADICAL PROSTATECTOMY (RP): RESULTS FROM THE SEARCH DATABASE (2011) (0)
- 736 PRO-INFLAMMATORY AND MITOGENIC ACTIVITY OF PERIPROSTATIC ADIPOSE TISSUE IN PROSTATE CANCER (2011) (0)
- Is time to castration resistant prostate cancer a potential intermediate end-point for time to metastasis among men initiating androgen deprivation therapy for non-metastatic prostate cancer with rapid PSA doubling time (<9 months)? (2022) (0)
- DYNAMIC SCREENING DETECTS PROSTATE CANCER (PC) EARLIER AND WOULD LEAD TO IMRPROVED CANCER CONTROL: RESULTS FROM THE DUKE PROSTATE CENTER AND THE SEARCH DATABASE (2008) (0)
- 902 PREDICTORS OF PROSTATE CANCER-SPECIFIC MORTALITY IN PATIENTS WITH RESIDUAL DISEASE AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2011) (0)
- MP53-12 LONG TERM ONCOLOGICAL OUTCOMES OF APICAL POSITIVE SURGICAL MARGINS AT RADICAL PROSTATECTOMY IN THE SHARED EQUAL ACCESS REGIONAL CANCER HOSPITAL (SEARCH) COHORT (2015) (0)
- Abstract B72: Metformin use and risk of biochemical recurrence following radical prostatectomy: Results from the SEARCH database (2012) (0)
- Seminar article Risk factors for male osteoporosis (2003) (0)
- Reply to the letter by Demark-Wahnefried et al. (2018) (0)
- DOES EARLY PSADT, CALCULATED STARTING AT THE FIRST DETECTABLE PSA AFTER RADICAL PROSTATECTOMY (RP), CORRELATE WITH STANDARD PSADT? A REPORT FROM THE SEARCH DATABASE GROUP (2008) (0)
- Evaluation of the ER{alpha} agonist, GTx-758 (250 mg daily), in men with metastatic (mCRPC) and nonmetastatic castration-resistant prostate cancer (nmCRPC). (2015) (0)
- MP82-15 DOES EARLY ANDROGEN DEPRIVATION THERAPY AFTER BIOCHEMICAL RECURRENCE FOLLOWING RADICAL PROSTATECTOMY INCREASE OVERALL SURVIVAL? RESULTS FROM SEARCH (2015) (0)
- PD28-05 FACTORS PREDICTING SKELETAL-RELATED EVENTS IN PATIENTS WITH BONE METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (2016) (0)
- MP57-03 IS ADVERSE PATHOLOGY AT THE TIME OF RADICAL PROSTATECTOMY A USEFUL PREDICTOR OF LONG-TERM OUTCOMES IN ACTIVE SURVEILLANCE CANDIDATES? RESULTS FROM THE SEARCH COHORT (2022) (0)
- Title Utilization and impact of surgical technique on the performance of pelvic lymph node dissection at radical prostatectomy : Results from the SEARCH database (2016) (0)
- MP21-03 SERUM LIPID PROFILE AT TIME OF ANDROGEN DEPRIVATION THERAPY AND RISK OF CASTRATION-RESISTANT PROSTATE CANCER: RESULTS FROM THE SEARCH DATABASE (2018) (0)
- OVER THE LAST 15+ YEARS, THE PERCENTAGE OF MEN UNDERGOING RADICAL PROSTATECTOMY WHO ARE CANDIDATES FOR ACTIVE SURVEILLANCE HAS NOT CHANGED: RESULTS FROM THE SEARCH DATABASE (2008) (0)
- Reply by Authors. (2019) (0)
- PD14-12 SECONDARY OUTCOMES OF A PROSPECTIVE RANDOMIZED TRIAL OF DIETARY CARBOHYDRATE RESTRICTION FOR MEN INITIATING ANDROGEN DEPRIVATION THERAPY: CARBOHYDRATE AND PROSTATE STUDY I (CAPS1) (2018) (0)
- 667: Pathological and Biochemical Outcomes after Radical Prostatectomy for Men with a Biopsy Gleason Score of 8 to 10 (2006) (0)
- 1464 EXTRACAPSULAR EXTENSION PREDICTS LATE RECURRENCE IN PATIENTS WHO ACHIEVE UNDETECTABLE PSA AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2011) (0)
- Risk Stratification of Men with Gleason 7–10 tumors by Primary and Secondary Gleason Score: Results from the SEARCH Database (2012) (0)
- PD16-10 RACE DOES NOT PREDICT SKELETAL RELATED EVENTS AND ALL-CAUSE MORTALITY IN MEN WITH CASTRATE RESISTANT PROSTATE CANCER (2020) (0)
- MP6-08 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE EFFECTS OF POMEGRANATE EXTRACT ON RISING PROSTATE SPECIFIC ANTIGEN (PSA) LEVELS IN MEN FOLLOWING PRIMARY THERAPY FOR PROSTATE CANCER (2015) (0)
- DO NOMOGRAMS PREDICT AGGRESSIVE RECURRENCE AFTER RADICAL PROSTATECTOMY MORE ACCURATELY THAN BIOCHEMICAL RECURRENCE ALONE (2009) (0)
- Abstract 880: Obesity predicts prostate cancer-specific mortality after radical prostatectomy: Results from the SEARCH database (2015) (0)
- Exercise for Prevention and Treatment of Prostate Cancer: Cellular Mechanisms (2010) (0)
- 2284 : Preoperative PSA Velocity Predicts for Relapse After Prostatectomy Only for Non-Obese (Low BMI) Patients (2006) (0)
- PD34-07 CAN GLEASON 7 PROSTATE CANCER EVER BE LOW-RISK? RESULTS FROM THE SHARED EQUAL ACCESS REGIONAL CANCER HOSPITAL (SEARCH) DATABASE (2015) (0)
- MP32-15 COMPARISON OF THE PROSTATE CANCER COMORBIDITY INDEX AND AMERICAN ANESTHESIOLOGY ASSOCIATION SCORE IN PREDICTION OF MORTALITY IN MEN UNDERGOING RADICAL PROSTATECTOMY (2021) (0)
- PREDICTORS OF CASTRATION RESISTANT PROSTATE CANCER IN MEN UNDERGOING SALVAGE ANDROGEN DEPRIVATION THERAPY - RESULTS FROM THE SEARCH DATABASE (2009) (0)
- 1648: Multi-Institutional Validation of the UCSF Cancer of the Rostate Risk Assessment (CAPRA) for Prediction of Recurrence Following Radical Prostatectomy (2006) (0)
- 600: Effect of Dietary Omega-6 Fatty Acid on Androgen-Independent Prostate Tumor Progression and Survival in Severe Combined Immunodeficiency Mice (2004) (0)
- WHAT ARE THE BEST CUT‐POINTS FOR PSA DOUBLING TIME IN MEN WITH NON‐METASTATIC CASTRATION‐RESISTANT PROSTATE CANCER?: MP20‐19 (2017) (0)
- 1497 OVERSTAGING HIGH-RISK PROSTATE CANCER MAY LEAD TO OVERTREATMENT: RESULTS FROM THE SEARCH DATABASE (2013) (0)
- Prostate Cancer: Localized (I)Podium Session 6357 RADICAL PROSTATECTOMY AND THE EFFECT OF CLOSE SURGICAL MARGINS: ANALYSIS FROM THE SEARCH DATABASE (2013) (0)
- MP35-16 IS KI67 PROGNOSTIC FOR AGGRESSIVE PROSTATE CANCER? A MULTICENTER REAL-WORLD STUDY (2018) (0)
- Abstract LB-458: Additive effects of caloric restriction and IGF-I receptor blockade on the progression of 22RV1 prostate cancer xenografts (2011) (0)
- MP64-15 ASSOCIATION BETWEEN DELAY TO SURGERY AND CLINICALLY MEANINGFUL OUTCOMES AMONG PATIENTS WITH INTERMEDIATE- AND HIGH-RISK LOCALIZED PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY: AN ASSESSMENT OF THE SEARCH DATABASE WITH INSIGHT INTO THE ROLE OF NEOADJUVANT ANDROGEN DEPRIVATION THERAPY (2021) (0)
- MP54-14 TIME TRENDS IN USE OF RADICAL PROSTATECTOMY BY TUMOR RISK AND LIFE EXPECTANCY IN A NATIONAL VA COHORT FROM 2000 TO 2017 (2019) (0)
- 997 RISK FOR RECURRENT PROSTATE CANCER INCREASES WITH CHOLESTEROL ON A CONTINUUM IN MEN WITH ABNORMAL CHOLESTEROL LEVELS - AN UPDATE FROM THE SEACH DATABASE (2011) (0)
- PD62-08 PREDICTED RISK OF PROSTATE CANCER-SPECIFIC MORTALITY ON ACTIVE SURVEILLANCE FOR MEN WITH FAVORABLE INTERMEDIATE RISK PROSTATE CANCER (2020) (0)
- A lifestyle intervention of weight loss via a low-carbohydrate diet plus walking to reduce metabolic disturbances caused by androgen deprivation therapy among prostate cancer patients: carbohydrate and prostate study 1 (CAPS1) randomized controlled trial (2019) (0)
- The Impact of Blue Light Cystoscopy Use Among Non-Muscle Invasive Bladder Cancer Patients in an Equal Access Setting: Implications on Recurrence and Time to Recurrence (2023) (0)
- MP09-18 BIOPSY-DETECTED GLEASON PATTERN 5 IS A PARTICULARLY STRONG PREOPERATIVE PREDICTOR OF RECURRENCE, METASTASIS, AND MORTALITY IN MEN WITH HIGH-RISK PROSTATE CANCER (2016) (0)
- Moreira DM, Aronson WJ, Terris MK, Kane CJ, Amling CL, Cooperberg MR, Boffetta P and Freedland SJ. Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration‐resistant prostate cancer, and mortality after radical prostatectomy. Cancer. 2014;120:1 (2015) (0)
- 338 DO REPEATED PROSTATE BIOPSIES WORSEN THE OUTCOME AMONG MEN WITH PROSTATE CANCER WHO HAVE A RADICAL PROSTATECTOMY? RESULTS FROM THE SEARCH DATABASE (2011) (0)
- Oncology Does Salvage Radiation Therapy Change the Biology of Recurrent Prostate Cancer Based on PSA Doubling Times? Results from the SEARCH Database (2012) (0)
- MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer (2019) (0)
- First-year weight loss with androgen-deprivation therapy increases risks of prostate cancer progression and prostate cancer-specific mortality: results from SEARCH (2019) (0)
- 1610: High-Risk Patients Undergoing Radical Prostatectomy Today are Less High-Risk than in the Past (2005) (0)
- Reply by Authors. (2022) (0)
- Impact of age, comorbidity, and PSA doubling time on long-term competing risks for mortality among men with non-metastatic castration-resistant prostate cancer (2017) (0)
- 16: Nerve Sparing Does not Increase the Risk of Biochemical Recurrence: Results from the Search Database (2007) (0)
- MP4-17 PATHOLOGIC GLEASON 8-10: DO ALL MEN DO POORLY? RESULTS FROM THE SEARCH DATABASE (2015) (0)
- PSA VELOCITY (PSAV) TO CANCER-SPECIFIC PSA (PSA(PCA)) RATIO INCREASES WITH HIGHER GLEASON SCORE: RESULTS FROM THE SEARCH DATABASE (2008) (0)
- 964 CIGARETTE SMOKING IS ASSOCIATED WITH SHORTER TIME FROM RADICAL PROSTATECTOMY TO METASTASIS: RESULTS FROM THE SEARCH DATABASE (2013) (0)
- A Case of an Invisible Ureteral Stent. (2018) (0)
- Obese men, higher PSA nadir values after radical prostatectomy (RP), and higher biochemical recurrence (BCR) rates: Results from the SEARCH database. (2011) (0)
- MP50-13 VALIDATION OF A BONE SCAN POSITIVITY RISK TABLE IN NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (2016) (0)
- Nutrition and prostate cancer : Hormone refractory prostate cancer (1999) (0)
- 997 DELAYED RADICAL PROSTATECTOMY IN GLEASON 7 PROSTATE CANCER DECREASES TIME TO BIOCHEMICAL RECURRENCE: RESULTS FROM THE SEARCH DATABASE (2012) (0)
- Reply by Authors. (2019) (0)
- MP42-09 PREDICTING BONE SCAN POSITIVITY IN CASTRATION-RESISTANT PROSTATE CANCER (2014) (0)
- 739 PHASE II PROSPECTIVE RANDOMIZED TRIAL OF ALTERING THE DIETARY RATIO OF OMEGA-6 TO OMEGA-3 FATTY ACIDS IN MEN UNDERGOING RADICAL PROSTATECTOMY (2011) (0)
- Session 3 Preclinical models with relevance to clinical cancer prevention (2004) (0)
- Radium-223 Utilization Patterns and Outcomes in Clinical Practice. (2022) (0)
- 387: The Optimal Timing, Cutoff and Method of Calculation of Preoperative PSA Velocity to Predict Relapse after Prostatectomy: A Report from Search (2007) (0)
- Clinical Outcomes for Patients With Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiation Therapy or Radical Prostatectomy: A Comparative Analysis (2016) (0)
- NOVEL RISK STRATIFICATION GROUPING USING STANDARD CLINICAL AND BIOPSY INFORMATION FOR PATIENTS UNDERGOING RADICAL PROSTATECTOMY: RESULTS FROM SEARCH: MP20‐02 (2017) (0)
- Impact of darolutamide on local symptoms: pre‐planned and post hoc analyses of the ARAMIS trial (2022) (0)
- Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease (2019) (0)
- Time from biopsy to radical prostatectomy by race in an equal-access healthcare system: Results from the SEARCH cohort. (2023) (0)
- 2060 DOES PSA DOUBLING TIME AFTER RADICAL PROSTATECTOMY CORRELATE WITH OVERALL SURVIVAL? A REPORT FROM THE SEARCH DATABASE GROUP (2010) (0)
- 292 DOES INITIATING STATIN THERAPY AFTER RADICAL PROSTATECTOMY REDUCE THE RISK FOR BIOCHEMICAL RECURRENCE? – RESULTS FROM THE SEARCH DATABASE (2010) (0)
- 1262: Men with Normal Pre-Operative Serum PSA Values have Better Biochemical Outcomes Following Radical Prostatectomy (2004) (0)
- 150 THE NATURAL HISTORY OF ULTRASENSITIVE PSA FOLLOWING RADICAL PROSTATECTOMY (2011) (0)
- MP53-02 IS CLINICAL STAGE T2C PROSTATE CANCER INTERMEDIATE OR HIGH-RISK DISEASE? (2015) (0)
- PREDICTORS OF SECONDARY TREATMENT FOLLOWING BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2009) (0)
- PD13-04 LONG-TERM COMPETING RISKS OF MORTALITY AMONG MEN WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY (2020) (0)
- Abstract LB-429: Synergistic effects of low-fat diet combined with IGF-I receptor blockade on 22RV1 prostate cancer xenografts (2010) (0)
- 81 EFFECT OF DIETARY OMEGA-6 FATTY ACID ON ANDROGEN-INDEPENDENT PROSTATE TUMOR PROGRESSION AND SURVIVAL IN SEVERE COMBINED IMMUNODEFICIENCY MICE. (2004) (0)
- Validation of the prostate cancer comorbidity index in predicting cause-specific mortality in men undergoing radical prostatectomy. (2022) (0)
- 145: A No-Carbohydrate Diet Significantly Delays Prostate Cancer Growth in an Animal Model (2007) (0)
- 474: Significance of the Apical Margin in Radical Prostatectomy: Results from the Search Database (2007) (0)
- Effect of dietary omega-3 fatty acids on castrate-resistant prostate cancer and tumor-associated macrophages (2019) (0)
- 442 EFFECT OF DIETARY OMEGA-6 FATTY ACID ON ANDROGEN-INDEPENDENT PROSTATE TUMOR PROGRESSION AND SURVIVAL IN SEVERE COMBINED IMMUNODEFICIENCY MICE. (2004) (0)
- PD34-10 IMPACT OF DAROLUTAMIDE ON LOCAL SYMPTOMS IN PATIENTS WITH NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER (2021) (0)
- MP60-12 DOES LARGER TUMOR VOLUME EXPLAIN THE HIGHER PROSTATE SPECIFIC ANTIGEN LEVELS IN BLACK MEN WITH PROSTATE CANCER —RESULTS FROM THE SEARCH DATABASE (2015) (0)
- MP34-13 COMBINATION THERAPY WITH RADIUM-223 AND ABIRATERONE OR ENZALUTAMIDE IN A LARGE REAL WORLD COHORT (2019) (0)
- VALIDATION OF STEPHENSON NOMOGRAM TO PREDICT PSA PROGRESSION FOLLOWING SALVAGE RADIOTHERAPY AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2009) (0)
- PD54-05 HALSTEADIAN VIEW OF PROSTATE CANCER: DOES REMOVING MORE NODES AT RADICAL PROSTATECTOMY AFFECT BIOCHEMICAL RECURRENCE? (2022) (0)
- 360 SHOULD CLINICAL STAGE T2C PROSTATE CANCER BE CLASSIFIED AS INTERMEDIATE- OR HIGH-RISK? - RESULTS FROM THE SEARCH DATABASE (2012) (0)
- Does salvage radiation therapy (SRT) change the biology of recurrent prostate cancer (PCa) based on PSA doubling times (PSADT)? Results from the SEARCH database. (2012) (0)
- Short title: Low Fat/Fish oil Diet, Serum Eicosanoids and Prostate Cancer (2013) (0)
- Phase II prospective randomized trial of weight loss prior to radical prostatectomy (2017) (0)
- MP87-03 EVALUATION OF THE ERα AGONIST, GTX-758 (250 MG DAILY), IN MEN WITH METASTATIC (MCRPC) AND NON-METASTATIC CASTRATION RESISTANT PROSTATE CANCER (NMCRPC) (2015) (0)
- Mp79-15 Radical Prostatectomy and the Effect of Close Surgical Margins: Analysis From the Search Database (2013) (0)
- Is biopsy Gleason sum an independent predictor of biochemical progression following radical prostatectomy after adjusting for the pathological Gleason sum? (2006) (0)
- MP22-06 SALVAGE RADIATION THERAPY FOR RECURRENT PROSTATE CANCER: CAN THE PROGNOSTIC GRADE GROUP SYSTEM INFORM TREATMENT TIMING? (2018) (0)
- Corrigendum re: "Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT)" [Eur Urol 2020;77:713-24]. (2021) (0)
- SMALL TRUS VOLUME PREDICTS CLINICALLY SIGNIFICANT GLEASON SCORE UPGRADING AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2008) (0)
- T1C DISEASE IN BLACK MEN: A MORE AGGRESSIVE DISEASE? RESULTS FROM THE SEARCH DATABASE (2008) (0)
- NATURAL HISTORY OF SALVAGE RADIOTHERAPY FOR RECURRENT PROSTATE CANCER: RESULTS FROM THE SEARCH DATABASE (2009) (0)
- Preclinical Development Effect of a Low-Fat Diet Combined with IGF-1 Receptor Blockade on 22 Rv 1 Prostate Cancer Xenografts (2012) (0)
- DOES PRACTICE REFLECT THE EVIDENCE? LYMPH NODE DISSECTION WITH RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2008) (0)
- Is There a Role for Medications to Reduce the Need for Prostate Biopsy (2013) (0)
- Validity of the National Death Index to ascertain the date and cause of death in men having undergone prostatectomy for prostate cancer (2019) (0)
- TITLE : Effect of a low-fat diet combined with IGF-1 receptor blockade on 22 Rv 1 prostate cancer xenografts (2012) (0)
- PD31-07 AGENT ORANGE AND LONG-TERM OUTCOMES AFTER RADICAL PROSTATECTOMY (2014) (0)
- 316 DECREASED MITOCHONDRIAL AND INSULIN PATHWAY GENE EXPRESSION SIGNAL IN PROSTATE CANCER XENOGRAFT MOUSE MODEL WITH VARYING DIETARY FAT SOURCES (2013) (0)
- 366 BIOPSY-DETECTED GLEASON PATTERN 5 PREDICTS RECURRENCE IN MEN WITH HIGH-RISK PROSTATE CANCER (2013) (0)
- 479 IS INFILTRATION OF TUMOR-ASSOCIATED MACROPHAGES PREDICTIVE OF BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY? (2012) (0)
- 237: Gene Expression Profiling of Prostate Cancers from Obese Men Identified HMGCS2 as a Novel Biomarker of Aggressive Prostate Cancer and as a Potential Therapeutic Target (2006) (0)
- 219 DIFFERENTIAL EFFECT OF CALORIC AND CARBOHYDRATE RESTRICTION ON PROSTATE TUMOR CANCER GROWTH AND GENE EXPRESSION IN A XENOGRAFT MODEL (2012) (0)
- Reply to the letter by Demark-Wahnefried et al. (2018) (0)
- Lifestyle, IGF-I and prostate cancer (2006) (0)
- 1038: Percent of Prostate Needle Biopsy Cores with Cancer from the Most Involved Side of the Biopsy is a Better Predictor of PSA Recurrence Following Radical Prostatectomy than the Total Percent of Cores with Cancer (2004) (0)
- OUTCOME AMONG MEN WITH PATHOLOGICAL GLEASON SUM 8-10 PROSTATE CANCER AT THE TIME OF RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2008) (0)
- Prostate Cancer Prostate-Specific Antigen following Surgery or Radiation for Phase II Study of Pomegranate Juice for Men with Rising Updated (2006) (0)
- 1638 UNILATERAL PROSTATE CANCER ANALYIS OF PREDICTORS IN SEARCH AND DUKE PROSTATE CENTER DATABASES (2012) (0)
- PD32-10 POSITIVE SURGICAL MARGINS IN RADICAL PROSTATECTOMY PATIENTS DO NOT PREDICT LONG-TERM ONCOLOGICAL OUTCOMES: RESULTS FROM SEARCH (2015) (0)
- MP37-08 THE ASSOCIATION BETWEEN DIABETES AND PROSTATE CANCER-SPECIFIC MORTALITY IS DIFFERENT IN OBESE AND NON-OBESE MEN AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2020) (0)
- Comparison of Low-Carbohydrate Vs . A Low-Fat Diet on Prostate Cancer Biomarkers (2014) (0)
- S&T-12 RACE DOES NOT PREDICT THE DEVELOPMENT OF METASTASES IN MEN WITH NON-METASTATIC CASTRATE RESISTANT PROSTATE CANCER (2016) (0)
- DOES PSADT AFTER RADICAL PROSTATECTOMY PREDICT OVERALL SURVIVAL?—A REPORT FROM THE SEARCH DATABASE GROUP (2009) (0)
- 679 LOW SERUM FOLATE IS A RISK FACTOR FOR BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY RESULTS FROM THE SEARCH DATABASE (2012) (0)
- MP32-05 CONTEMPORARY HISTORY OF PROGRESSION FOLLOWING ANDROGEN DEPRIVATION THERAPY FOR BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY (2021) (0)
- 697: Prostate Size is Inversely Associated with Risk of High-Grade, Advanced Prostate Cancer, and Biochemical Progression Following Radical Prostatectomy (2005) (0)
- Upgrading and Downgrading of Prostate Needle Biopsies: Risk Factors and Clinical Implications (2011) (0)
- 1417: Growth Inhiditory Effects of a Low-Fat Diet on Prostate Cancer Cells in Vitro: Results of a Prospective Randomized Dietary Intervention Trial in Men with Prostate Cancer (2005) (0)
- Efficacy and safety of darolutamide in Black/African-American patients from the phase III ARAMIS study. (2023) (0)
- PD13-10 DIABETES AND PROSTATE CANCER OUTCOMES IN MEN WITH NONMETASTATIC CASTRATE-RESISTANT PROSTATE CANCER: RESULTS FROM THE SEARCH COHORT (2022) (0)
- Abstract CN06-03: Green tea and pomegranate: The role of metabolites in chemoprevention (2010) (0)
- MP26-19 FURTHER DEFINING THE NATURAL HISTORY OF BIOCHEMICAL PROGRESSION FOLLOWING RADICAL PROSTATECTOMY: DOES PSA DOUBLING TIME CHANGE WITH TIME? (2021) (0)
- 457: Agent Orange Exposure among Black Men is a Stronger Predictor of PSA Recurrence and Rapid Post-Recurrence Psadt than among White Men (2007) (0)
- Title Is clinical stage T 2 c prostate cancer an intermediate-or high-risk disease ? (2015) (0)
- HIGHER CHOLESTEROL INCREASES THE RISK OF BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE GROUP (2008) (0)
- MP14-12 OBESE CASTRATION-RESISTANT PROSTATE CANCER PATIENTS MAY BE AT A LOWER RISK OF METASTASIS AND ALL-CAUSE MORTALITY: RESULTS FROM THE SEARCH DATABASE (2015) (0)
- Global Igfbp 1 deletion does not af fect prostate cancer development in a c-Myc transgenic mouse model (2011) (0)
- PD10-06 THE IMPACT OF PRIOR LOCAL THERAPY ON OVERALL SURVIVAL IN MEN WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: RESULTS FROM SEARCH (2018) (0)
- MP34-10 PREDICTORS OF SKELETAL RELATED EVENTS AND OVERALL MORTALITY IN MEN WITH METASTATIC, CASTRATION-RESISTANT PROSTATE CANCER: RESULTS FROM THE SEARCH DATABASE (2019) (0)
- DO SICKER PEOPLE HAVE WORSE PROSTATE CANCER‐SPECIFIC OUTCOMES AFTER RADICAL PROSTATECTOMY? RESULTS FROM SEARCH: PD40‐12 (2017) (0)
- TIMING OF PSA NADIR AFTER RADICAL PROSTATECTOMY AND RISK OF BIOCHEMICAL RECURRENCE: DOES IT MATTER? RESULTS FROM THE SEARCH DATABASE: MP47‐09 (2017) (0)
- LYCOPENE AND CHEMOPREVENTION OF PROSTATE CANCER IN THE TRAMP MODEL (2009) (0)
- Monocyte counts and prostate cancer outcomes in white and black men: results from the SEARCH database (2021) (0)
- Original Article Association between tumor-associated macrophage infiltration, high grade prostate cancer, and biochemical recurrence after radical prostatectomy (2013) (0)
- MP67-09 RELATIONSHIP BETWEEN SKIN CANCER AND AGGRESSIVE PROSTATE CANCER: RESULTS FROM THE SEARCH DATABASE (2023) (0)
- Title Racial Differences in the Association Between Preoperative Serum Cholesterol and Prostate Cancer Recurrence : Results from the SEARCH Database (2016) (0)
- The impact of blue light cystoscopy use among patients with non-muscle invasive bladder cancer in an equal access setting. (2023) (0)
- A phase II open-label trial of GTx-758 in men with castration-resistant prostate cancer: Final analysis of the primary endpoint. (2016) (0)
- MP32-12 HOW SURGEONS EARN THEIR KEEP: DATA FROM THE CMS DATA RELEASE (2015) (0)
- Is clinical stage T2c prostate cancer intermediate- or high-risk disease? Results from the SEARCH database. (2012) (0)
- Prostate Cancer: Localized VIIModerated Poster1465 DOES SALVAGE RADIATION THERAPY CHANGE THE BIOLOGY OF RECURRENT PROSTATE CANCER BASED ON PSA DOUBLING TIMES? RESULTS FROM THE SEARCH DATABASE (2012) (0)
- VALIDATION OF THE 2015 PROSTATE CANCER PROGNOSTIC GRADE GROUPS FOR PREDICTING LONG‐TERM ONCOLOGIC OUTCOMES IN A SHARED EQUAL ACCESS HEALTH SYSTEM.: PD03‐10 (2017) (0)
- Abstract PR-07: Efficacy and safety of darolutamide in Black/African American patients from the phase III ARAMIS trial (2022) (0)
- 313 LOW FAT FISH OIL (LFFO) DIET DECREASES PRO-INFLAMMATORY EICOSANOIDS AND PROSTATE CANCER CELL CYCLE PROGRESSION (CCP) SCORE IN MEN UNDERGOING RADICAL PROSTATECTOMY (2013) (0)
- A modeling study to estimate prostate cancer-specific mortality on active surveillance for men with favorable intermediate-risk prostate cancer: Results from the SEARCH cohort. (2023) (0)
- Is body composition linked to prostate cancer survival? (2021) (0)
- 459: Obesity, Risk of Biochemical Recurrence, and PSADT after Radical Prostatectomy (2007) (0)
- Does larger tumor volume explain the higher prostate specific antigen levels in black men with prostate cancer--Results from the SEARCH database. (2015) (0)
- MP32-18 METABOLIC SYNDROME AND LONG-TERM PROSTATE CANCER OUTCOMES AFTER RADICAL PROSTATECTOMY (2021) (0)
- IBJU | HigH serum folate is associated witH reduced biocHemical recurrence after radical prostatectomy : results from tHe searcH database 513 INtRODUctION Folate is a water-soluble (2013) (0)
- Neutrophil, lymphocyte and platelet counts, and risk of prostate cancer outcomes in white and black men: results from the SEARCH database (2018) (0)
- DO H2 BLOCKERS LOWER SERUM PSA RESULTS? - DATA FROM THE SEARCH DATABASE (2009) (0)
- 661 RACE AND LONG-TERM OUTCOMES AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2010) (0)
- NATURAL HISTORY OF PERSISTENTLY ELEVATED PSA AFTER RADICAL PROSTATECTOMY: RESULTS FROM THE SEARCH DATABASE (2009) (0)
- Title Trends in Radiation-Induced Second Malignancy With Increased Utilization of Intensity Modulated Radiation Therapy for Localized Prostate Cancer (2016) (0)
- MP87-07 STATIN USE IS ASSOCIATED WITH IMPROVED PROSTATE CANCER-SPECIFIC OUTCOMES IN WHITE BUT NOT BLACK MEN INITIATING ANDROGEN DEPRIVATION THERAPY (2018) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With William J. Aronson?
William J. Aronson is affiliated with the following schools: